September Media Test Schedule Set for Senetek's Kinetin Plus Infomercial; Senetek Targets Launch of Kintein Plus(TM) Interactive Website For September 18
Tuesday September 9, 4:43 pm ET
NAPA, Calif., Sept. 9 /PRNewswire-FirstCall/ -- Senetek PLC (Nasdaq: SNTK - News), www.senetekplc.com , a biopharmaceutical company focused on developing and marketing products that meet under-met consumer needs for aging well, today announced it has finalized the long form media test schedule for its newly created program-length infomercial for Kinetin Plus(TM), Senetek's new skincare regimen featuring unique formulations of its patented Kinetin cytokinin and Kinetin combination formulations with other highly effective ingredients, many of them proprietary. The program features noted skincare specialist Jessica Anawalt and interviews with the Ph.D. co-discoverers of Kinetin's remarkable anti-aging effects, who discuss the science behind skin wellness and the proven benefits of Kinetin use. Viewers will be offered a specially-priced four-product assortment with additional purchase opportunities. One percent of all proceeds of infomercial sales are being donated by Senetek to the Skin Cancer Foundation.
The test schedule, developed for Senetek by Zephyr Media Group, the media agency for such successful infomercial campaigns as Sharper Image®, calls for placements beginning September 11 and running through September 23 on a mix of national cable networks including ABC Family, A&E, Discovery, Food, Life, Oxygen and Women's Entertainment. The time slots selected, which are primarily late night and early morning, are designed to maximize feedback about the program's effectiveness with a wide range of viewers based on repeat viewership at a manageable cost. Based on analysis of the data generated and information learned, any indicated program refinements will be executed prior to full national roll-out of the infomercial.
Senetek also announced a September 18 scheduled launch date for its www.kinetin.com , interactive website for direct consumer purchases of the full Kinetin Plus line. The website will bring consumers the full Kinetin story, including clinical studies conducted at a prestigious medical institution's dermatology department along with unretouched scientific photographs of 48-week study results. This highly user-friendly and secure site includes the ability to enroll in the Kinetin Plus "Looking Good Feels Good" continuity program. The site will offer all eight Kinetin Plus products: Chest & Neck Treatment Lotion, Eye Area Eraser Plus Vitamin C & E Booster, Gentle Foaming Cleanser, Intense Serum Plus 10% Vitamin C Booster, Night Renewal Cream, Refresh Finishing Toner, Smoothing Lip Balm SPF 20, and Sun Protection Lotion SPF 15 (the latter two bearing the Skin Cancer Foundation Seal).
Commenting on these developments, Frank J. Massino, Chairman and CEO of Senetek, stated, "Kinetin's effectiveness and positive consumer reception are attested by the success of our licensees' product lines, including ICN Pharmaceuticals' Kinerase®, Almay's Kinetin skin care and color cosmetics lines and The Body Shop's Skin Releaf®, but this is the first Kinetin skincare regimen available directly from Senetek. Kinetin Plus(TM) affords us the opportunity to offer consumers unique Kinetin formulations and combinations of Kinetin with other proprietary active ingredients, and a base upon which to build an expanding Kinetin franchise."
Visit Senetek PLC's web site: senetekplc.com
Senetek PLC Investor Relations Contact:
1-707-226-3900 ext. 102
Email: pknopick@eandecommunications.com
Safe Harbor Statement:
This news release may contain statements that may be considered "forward- looking statements" under the federal securities laws, including statements concerning the eventual national roll-out of the infomercial, the potential success of the Kinetin Plus product line and the hoped-for benefits of this product launch. Forward-looking statements by their nature involve substantial uncertainty and there can be no assurance that actual results or events will not differ materially from those described in the forward-looking statements as a result of various factors, including the risks and uncertainties described in the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2002 and Quarterly Reports on Form 10-Q for subsequent calendar quarters of 2003, filed with the Securities and Exchange Commission. In addition, while the Company has attempted to identify in those filings the principal factors that it believes could result in such material differences, there can be no assurance that it has identified all of such factors or all of the ways in which such factors may affect future results or events.
Source: Senetek PLC |
